Chronic brucellosis--clinical response to reduction of suppressor T lymphocytes by cyclophosphamide/prednisone
Thornes, R.D.; Early, A.M.; Hogan, B.L.; Reen, D.
Irish Medical Journal 75(11): 423-424
1982
ISSN/ISBN: 0332-3102 PMID: 7174262 Document Number: 188146
Document emailed within 1 workday
Related Documents
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958Smith, J.B.; Eaton, G.J. 1976: Suppressor cells in spleens from "nude" mice: their effect on the mitogenic response of B lymphocytes Journal of Immunology 117(1): 319-322
Stäb, F.; Austrup, F.; Kölsch, E. 1990: Regulation of the anti-alpha(1----3) dextran IgG antibody response of BALB/c mice by idiotype-specific T suppressor lymphocytes Journal of Immunology 144(1): 53-59
Elgert, K.D.; Farrar, W.L. 1978: Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages Journal of Immunology 120(4): 1345-1353
Meuer, S.C.; Cooper, D.A.; Hodgdon, J.C.; Hussey, R.E.; Morimoto, C.; Schlossman, S.F.; Reinherz, E.L. 1983: Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations Journal of Immunology 131(3): 1167-1172
Zucker, R.M.; Cassen, B. 1974: Effect of chemotherapy with cyclophosphamide on the buoyant density separation and volume distributions of lymphocytes in chronic lymphocytic leukemia and lymphosarcoma Journal of the National Cancer Institute 52(6): 1691-1697
Ferrari, A.; Pasqualetti, D.; Del Bianco, P.; Gandolfo, G.M.; Chistolini, A.; Mazzucconi, M.G. 1991: Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications Haematologica 76(4): 342-345
Chiariello, M.; Sardi, B.; Piacenza, G.; Pesce, E. 1978: Effect of decaspiride on the immunosuppressive action of prednisone, dexamethasone and cyclophosphamide Bollettino Chimico Farmaceutico 117(5): 280-288
Vila Justribo, M.; Duce Gracia, F.; Bello Dronda, S.; Larrad Mur, L. 1986: Study of helper T lymphocytes and suppressor T lymphocytes in respiratory allergy and their modifications in relation to symptomatology Allergologia et Immunopathologia 14(4): 319-324
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Flores, M.; Gudiño Pérez, R.; Ríos Prado, R.; Almedia Arvizu, V.M.; Castrejón Vázquez, M.I.; Ocampo, A.A. 2001: Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine Revista Alergia Mexico 48(3): 75-79
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Wilson, K.; Shelley, W.; Belch, A.; Brandes, L.; Bergsagel, D.; Klimo, P.; White, D.; Willan, A. 1987: Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma Cancer Treatment Reports 71(10): 981-982
Maravi-Poma, E.; Murie, M.; Gamboa, J.; Díaz, R.; Rivero-Puente, A. 1982: Brucellosis: study of 222 cases. III. Chronic brucellosis. Prospective clinical study of 36 cases Revista Clinica Espanola 166(3-4): 101-105
Polding, J.B. 1948: Research into contagious abortion of cattle, sheep and goats. Brucellosis in India. I. The occurrence of brucellosis in India. II. Comparative susceptibility. III. The dissemination of brucellosis in India. IV. Bacteriology of Indian strains. V. Diagnosis. VI. Brucellosis and public health. VII. The control of brucellosis in India. VIII. Specific abortion, other than brucellosis. IX. Non-specific abortion Indian Journal of Veterinary Science and Animal Husbandry 18(3): 115-193
Polding, J.B. 1948: Research into contagious abortion of cattle, sheep and goats. Brucellosis in India. I. The occurrence of brucellosis in India. II. Comparative susceptibility. III. The dissemination of brucellosis in India. IV. Bacteriology of Indian strains. V. Diagnosis. VI. Brucellosis and public health. VII. The control of brucellosis in India. VIII. Specific abortion, other than brucellosis. IX. Non-specific abortion Indian Journal of Veterinary Science and Animal Husbandry 18(3): 115-193
Ho, M.K.; Kong, A.S.; Morse, S.I. 1980: The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. V. Modulation of T cell proliferation by helper and suppressor lymphocytes Journal of Immunology 124(1): 362-369
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Dobracki, W.; Gładysz, A.; Dobracka, B. 1991: Epidemiological and clinical analysis of chronic brucellosis and new Brucella infections Przeglad Epidemiologiczny 45(4): 391-394